To assess and compare the levels of functioning in patients with major depressive disorder treated with either duloxetine with a daily dose of ≤60 mg or a selective serotonin reuptake inhibitor (SSRI) as monotherapy for up to 6 months in a naturalistic setting in East Asia. In addition, this study examined the impact of painful physical symptoms (PPS) on the effects of these treatments.
Functioning in patients with major depression treated with duloxetine or a selective serotonin reuptake inhibitor in East Asia / Novick, Diego; Montgomery, William; Haro, Josep Maria; Moneta, Maria Victoria; Zhu, Gang; Yue, Li; Hong, Jihyung; Dueñas, Héctor; Brugnoli, Roberto. - In: NEUROPSYCHIATRIC DISEASE AND TREATMENT. - ISSN 1176-6328. - STAMPA. - 12:(2016), pp. 383-392. [10.2147/NDT.S100675]
Functioning in patients with major depression treated with duloxetine or a selective serotonin reuptake inhibitor in East Asia
BRUGNOLI, ROBERTO
2016
Abstract
To assess and compare the levels of functioning in patients with major depressive disorder treated with either duloxetine with a daily dose of ≤60 mg or a selective serotonin reuptake inhibitor (SSRI) as monotherapy for up to 6 months in a naturalistic setting in East Asia. In addition, this study examined the impact of painful physical symptoms (PPS) on the effects of these treatments.| File | Dimensione | Formato | |
|---|---|---|---|
|
Novick_Functioning_2016.pdf
solo gestori archivio
Tipologia:
Documento in Post-print (versione successiva alla peer review e accettata per la pubblicazione)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
730.11 kB
Formato
Adobe PDF
|
730.11 kB | Adobe PDF | Contatta l'autore |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
